Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.
News|Videos|August 24, 2026
APAO 2026: Oncology PAs Convene for 29th Annual Symposium
Author(s)Alex Biese
Fact checked by: By ONN Staff
Experts at the 2026 APAO Symposium highlighted patient education, clinical trial updates, and professional development in cancer care.
Advertisement
Advertisement
Experts including physician associates (PAs), nurse practitioners (NPs), pharmacists, and physicians, gathered at the New York Marriott Marquis from August 13 to 16, 2026, for the 29th Annual Oncology Symposium for the Healthcare Provider. Presented by the Association of PAs in Oncology (APAO), the four-day conference brought together over 200 healthcare professionals with the goal of translating clinical vision into reality. The event focused on creating a dedicated environment for clinical learning, networking, and professional development.
Related to this article
At ASTRO 2026, Suresh Rana details how AI-driven contouring accelerates care timelines, requiring rigorous team monitoring and early nursing input.
At ASTRO 2026, Dr. Erica Braschi Jordan details toxicity tracking, physical therapy referral, and quality of life in proton regional nodal irradiation.
At ASTRO 2026, Dr. Mishaal Munir details how nurse-led triage workflows and prompt symptom escalations improve care for breast cancer brain metastases.
ASTRO 2026 presenter Kayla Kafka-Peterson details an Adapt-Adopt-Build model to bridge global brachytherapy nursing gaps and standardize perioperative care.
At ASTRO 2026, Dr. Nitin Ohri details additive versus synergistic toxicities when combining radiation with novel systemic therapies in clinical trials.
APHON 2026 speaker Amy C. Haskamp, CNS, discusses tiered self-care tactics and boundaries to help pediatric oncology nurses navigate emotional distress and burnout.
At ASTRO 2026, DJohn Hillson details how early post-surgical radiation education within 6 weeks improves outcomes for head and neck cancer patients.
Advertisement
Advertisement